The transmembrane domain of the oncogenic mutant ErbB-2 receptor: a structure obtained from site-specific infrared

Andrew J Beevers1, Andreas Kukol

  • 1Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK.

Insights

Researchers determined the atomic structure of the oncogenic ErbB-2 transmembrane domain dimer. This structure reveals a right-handed alpha-helical bundle, crucial for understanding uncontrolled cell division in cancer.

Area of Science:

  • Biophysics
  • Structural Biology
  • Molecular Oncology

Background:

  • ErbB-2 (also known as HER2) is an epidermal growth factor receptor.
  • An oncogenic mutation (Val664Glu) in the rat neu gene's transmembrane domain causes ErbB-2 dimerization and uncontrolled cell proliferation, leading to tumor formation.

Purpose of the Study:

  • To determine the experimentally defined atomic structure of the mutant ErbB-2 transmembrane domain dimer.
  • To elucidate the structural basis of permanent dimerization and its role in oncogenesis.

Main Methods:

  • Site-specific infrared dichroism (SSID) using 13C18O-labeled transmembrane peptides.
  • Experimental determination of alpha-helical constraints and orientational data (helix tilt).
  • Conformational search combined with molecular dynamics simulations in a lipid bilayer.

Main Results:

  • The study derived the alpha-helical structure of the mutant transmembrane domain dimer.
  • SSID data indicated local helix tilt angles ranging from 28° to 22°.
  • An experimentally defined atomic structure revealed a right-handed alpha-helical bundle, contrasting with previous left-handed models. Key residues (Ile659, Val663, Leu667, Ile671, Val674, Leu679) form the dimerisation interface.
  • Spacious Glu664 residues interact with water, not directly with each other, facilitating tight helical packing.

Conclusions:

  • The determined right-handed helical bundle structure provides a precise atomic model for the ErbB-2 transmembrane domain dimer.
  • This structure clarifies the mechanism of permanent dimerization and offers insights into ErbB-2-driven oncogenesis.
  • Findings contrast with prior computational models and highlight the role of water in stabilizing the dimer interface.

Related Concept Videos

Insertion of Single-pass Transmembrane Proteins in the RER01:26

Insertion of Single-pass Transmembrane Proteins in the RER

Integral membrane proteins are proteins adhered to the lipid bilayer of a cell organelle or membrane. They can be of two types: transmembrane integral proteins that span the lipid bilayer and monotopic proteins that are attached to either side of the membrane but do not pass through it.
Integral transmembrane proteins possess transmembrane and extra membrane domains. The transmembrane domains are primarily made of 20-25 hydrophobic amino acids arranged in a helical secondary confirmation. These...
Insertion of Multi-pass Transmembrane Proteins in the RER01:29

Insertion of Multi-pass Transmembrane Proteins in the RER

The rough ER membrane synthesizes, assembles, and embeds transmembrane proteins in diverse topologies. These proteins function as transporters or channels and can remain in the ER membrane or are sent to the Golgi complex, lysosome, and cell membrane.
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Multi-pass Transmembrane Proteins and β-barrels01:09

Multi-pass Transmembrane Proteins and β-barrels

In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...